Search filters

List of works by Alain Ravaud

A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.

scientific article

A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.

scientific article published on 24 November 2011

A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France

scientific article published on 10 February 2017

A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy ⬇️

scientific article published on July 15, 1998

A survey in general practice about undergraduate cancer education: results from Gironde (France)

scientific article published on 01 January 1991

AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.

scientific article

Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordeaux University Hospital

scientific article published on 16 June 2020

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.

scientific article published on 26 September 2017

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

scientific article

Adjuvant therapy by BCG of non-Hodgkin's malignant lymphomas in a controlled trial: an update

scientific article published on 01 January 1989

Adverse effects of interleukin 2

scientific article published on November 1, 1991

Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer

scientific article published on April 2014

Amplification of epidermal growth factor receptor gene in renal cell carcinoma

article

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

scientific article

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

scientific article published on 8 January 2013

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial

scientific article

Are we ready for day-case partial nephrectomy?

scientific article published on 16 December 2015

Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer.

scientific article published in May 2009

Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT).

scientific article

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

scientific article published in January 2002

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

scientific article published on 18 December 2017

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

scientific article published on 01 October 2020

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

scientific article published on 4 December 2017

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

scientific article published on 4 April 2017

Axitinib: a review of its safety and efficacy in the treatment of adults with advanced renal cell carcinoma.

scientific article published on 29 October 2013

Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events

scientific article published in 2021

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

scientific article

Bladder cancer and new drugs

scientific article published in January 2010

Bladder cancer in patients after organ transplantation.

scientific article published on September 2010

Cabozantinib: Mechanism of action, efficacy and indications

scientific article published on 3 May 2017

Cancer chemotherapy in the elderly: a series of 51 patients aged greater than 70 years

scientific article published on 01 January 1991

Cardiomyopathy after acute myocardial infarction after therapy with interleukin-2 and tumour infiltrating lymphocytes

scientific article published on 01 January 1992

Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma.

scientific article published on 9 January 2009

Cell therapy in renal cell carcinoma

scientific article published on 01 August 2003

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

scientific article published on 04 June 2018

Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study

scientific article published on 01 January 2015

Clinical biomarkers of response in advanced renal cell carcinoma ⬇️

scientific article published on August 7, 2013

Colonic metastasis of a renal carcinoma. A case report

scientific article published on 01 June 1992

Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma

scientific article published on 01 July 2011

Combination therapy in metastatic renal cell cancer.

scientific article published on August 2013

Combined radiofrequency ablation and antiangiogenic drug for the treatment of recurrent renal tumor

scientific article published on 09 August 2008

Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia

scientific article published on 11 April 2007

Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape

scientific article published on 01 July 1999

Drug Interaction With Sunitinib and the Evidence of Therapeutic Drug Monitoring: A Case Report and Review of the Literature.

scientific article

Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.

scientific article published on 11 February 2014

Editorial Comment to Therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma ⬇️

scientific article published on May 31, 2012

Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort

scientific article published on 14 April 2016

Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.

scientific article

Efficacy of Rechallenge of Metastatic Renal Cell Carcinoma Patient With Sunitinib After Prior Resistance to Axitinib: Case Report and Review of the Literature

scientific article published on 22 April 2016

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

scientific article (publication date: 9 August 2008)

Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors.

scientific article

Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU.

scientific article published in January 2010

Emerging antiangiogenics for renal cancer.

scientific article published on December 2013

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

scientific article published on 22 March 2012

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.

scientific article

Experimental characterization of subwavelength diffraction gratings by an inverse-scattering neural method

scientific article published on 01 December 2002

Exposure-response relationships in patients with metastatic renal cell carcinoma receiving sunitinib: maintaining optimum efficacy in clinical practice.

scientific article published on June 2011

First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma

scientific article published on 11 April 2008

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†.

scientific article published on 23 March 2015

Functional decline in older patients with cancer receiving first-line chemotherapy

scientific article published on 23 September 2013

Gastric lipase in alcoholic pancreatitis. Comparison of secretive profiles following pentagastrin stimulation in normal adults and patients with pancreatic insufficiency

scientific article published on 01 July 1990

Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group

article

Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial ⬇️

scientific article published on November 16, 2001

Granulocyte-macrophage colony-stimulating factor in established febrile neutropenia

scientific article published on 01 September 1999

Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial

scientific article published on 01 September 1998

Hand-foot syndrome and sorafenib

scientific article published in February 2009

High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter study

scientific article published on 01 November 1994

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment

scientific article published on 12 June 2017

How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study.

scientific article

How to optimise treatment compliance in metastatic renal cell carcinoma with targeted agents

scientific article published on 01 May 2009

How to report toxicity associated with targeted therapies?

scientific article

Immune biomarkers predictive for disease-free survival with adjuvant sunitinib in high-risk locoregional renal cell carcinoma: from randomized phase III S-TRAC study.

scientific article

Immune checkpoint inhibitors and elderly people: A review

scientific article

Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment

scientific article published on 3 November 2016

In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates

scientific article published on 01 December 2000

In vitro production of human antigen presenting cells issued from bone marrow of patients with cancer

scientific article published on 01 October 1997

Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma.

scientific article published on 11 June 2012

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

scientific article

Interferon alpha for the treatment of advanced renal cancer.

scientific article

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

scientific article published in June 2004

Intérêt des anti-angiogéniques dans le cancer du rein localement avancé et métastatique en situation néo-adjuvante : à propos de 2 cas

scientific article published on 01 July 2008

Investigation of total and conjugated bilirubin determination during the neonatal period

scientific article published on 01 August 1993

Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?

scientific article published on 13 December 2016

Laparoscopic radical prostatectomy in renal transplant recipients.

scientific article published on 8 July 2009

Lapatinib and renal cell carcinoma

scientific article published on 09 August 2012

Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy

article

Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up

scientific article published on 03 December 2010

L’imagerie d’évaluation thérapeutique en pratique clinique d’oncologie urologique

scientific article published on 05 April 2014

Management of Immune Checkpoint Inhibitor Toxicities

scientific article published on 28 September 2020

Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.

scientific article published on 08 April 2011

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial

scientific article

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy.

scientific article published on 11 January 2016

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.

scientific article

Metronomic chemotherapy for renal cancer in the landscape of targeted therapy.

scientific article published in April 2010

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

scientific article

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.

scientific article published on 15 November 2014

Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma

scientific article published on 13 August 2014

Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features

scientific article published on 16 June 2015

New challenges in kidney cancer therapy: bevacizumab

scientific article published on 01 July 2007

New entities in pathological classification and new therapeutic options in renal cell carcinoma

scientific article published in January 2006

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

scientific article published on 21 March 2018

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

scientific article published on 25 September 2015

Néphrectomie partielle laparoscopique robot-assistée après traitement néoadjuvant

scientific article published on 30 October 2014

Optimal management of renal cell carcinoma in the elderly: a review

scientific article published on 19 April 2013

Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications.

scientific article published on 30 January 2013

Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma.

scientific article published on December 2014

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials

scientific article published on 27 April 2016

Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon‐α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial ⬇️

scientific article published on October 13, 2010

Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma ⬇️

scientific article published on February 12, 2012

PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation.

scientific article published on 12 December 2006

Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).

scientific article published on 11 January 2014

Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study

scientific article published on 29 November 2018

Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.

scientific article published in June 1989

Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction ⬇️

scientific article published on September 21, 2012

Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours.

scientific article published on 9 January 2013

Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study

scientific article

Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study.

scientific article published on 5 September 2017

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

scientific article published on 01 February 2003

Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinoma

scientific article published on 01 January 1998

Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

scientific article published in April 1999

Predictors of early death risk in older patients treated with first-line chemotherapy for cancer

scientific article published on 16 April 2012

Present achievements in the medical treatment of metastatic renal cell carcinoma.

scientific article

Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts

scientific article published on 7 August 2017

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

scientific article published on 30 September 2014

Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941

scientific article published on 17 September 2007

Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

scientific article published on 12 February 2005

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

scientific article published on 01 September 2002

Progression beyond nivolumab: Stop or repeat? Dramatic responses with salvage chemotherapy

scientific article published on 24 April 2018

Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature

scientific article published on 03 January 2013

Protein kinase inhibitors in renal cell carcinoma.

scientific article published on 16 December 2013

Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib

scientific article published on 13 June 2017

Pulmonary aspergilloma: an unexpected complication of radiofrequency ablation in the management of targeted therapy for a patient with metastatic renal cell carcinoma.

scientific article

Quelle pratique de la néphrectomie partielle en France ?

article

RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma

scientific article published on 7 April 2015

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma ⬇️

scientific article

Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer.

scientific article published on 13 April 2007

Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer

scientific article published on 01 September 2008

Rationale for the local treatment of metastases

scientific article

Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.

scientific article published on June 2017

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

scientific article published on 01 April 1998

Relationship between Pulmonary Adverse Events and Everolimus Exposure in Japanese and Non-Japanese Patients: A Meta-Analysis of Oncology Trials.

scientific article published on 21 February 2017

Relationship between everolimus exposure and safety and efficacy: meta-analysis of clinical trials in oncology

scientific article published on 9 December 2013

Relay chemotherapy using continuous perfusion of cisplatin and fluoro-uracil in advanced cancer of the breast. Analysis of a series of 50 cases

scientific article published in April 1990

Renal involvement in cancer and renal paraneoplastic syndromes

scientific article

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group

scientific article published on 01 September 1999

Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma

scientific article published on June 1, 1997

Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours

scientific article published on 21 February 2014

Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort

scientific article published on 23 August 2015

Sequential sorafenib and sunitinib for renal cell carcinoma.

scientific article published on 17 May 2009

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.

scientific article published on 28 March 2018

Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study

scientific article published on 15 December 2016

Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie ⬇️

scientific article published on August 1, 1998

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.

scientific article

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

scientific article published on 03 June 2018

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas

scientific article published on 13 January 2017

Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort

scientific article published on 5 December 2013

Symptomatic neurological epidural metastasis with interleukin-2 therapy in metastatic renal cell carcinoma

scientific article published on 01 July 2002

Systemic therapy of renal cell carcinoma

scientific article

Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year ⬇️

scientific article published on February 1, 2012

Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways

scientific article

Targeted therapy and elderly people: A review.

scientific article published on 14 November 2016

Targeted therapy for locally advanced and/or metastatic bladder cancer

scientific article published on 26 June 2008

Taxane-induced glaucoma

scientific article published on 01 October 1999

Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients

scientific article published on 27 February 2013

The experimental renal cell carcinoma model in the chick embryo

scientific article

The role of surgery for metastatic renal cell carcinoma in the era of targeted therapies

scientific article published on 30 March 2013

Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux

scientific article published on 28 October 2009

Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkers.

scientific article published on 28 May 2012

Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?

scientific article published on September 2012

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025.

scientific article published on 12 April 2017

Treatment of spinal metastases in renal cell carcinoma: A critical review

scientific article published on 06 March 2018

Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies.

scientific article published on January 2011

Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study.

scientific article

Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancer

scientific article published on November 1, 2010

UFT and oral calcium folinate as first-line chemotherapy for metastatic gastric cancer

scientific article published on 01 July 1999

Update on the medical treatment of metastatic renal cell carcinoma

scientific article published on 05 May 2008

VEGFR TKI 'resistance' or transient clinical insensitivity to VEGFR TKI in metastatic renal cell carcinoma

scientific article published on 26 November 2009

Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib

article

Vinorelbine/5-FU combination in metastatic breast cancer chemotherapy. A retrospective study of 63 cases

scientific article published on 01 February 1996

What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI? ⬇️

scientific article published on July 23, 2012

[Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light?]

scientific article published on 01 September 2014

[Bladder cancer. Editorial]

scientific article published on 01 January 2010

[Cancer of the prostate: recent findings and the immediate future]

scientific article published on 01 July 2007

[Cell therapy in solid tumors]

scientific article published on 01 January 2001

[Does surgery promote the development of metastasis in melanoma?]

scientific article published on 01 August 2000

[Is the incidence of painless chronic pancreatitis underestimated?]

scientific article published on 01 June 1989

[Management of muscle invasive bladder in elderly]

scientific article published on 01 March 2010

[Management of side effects of targeted therapies in renal cancer: iatrogenic side effects]

scientific article published on 01 January 2011

[Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult]

scientific article published on 01 January 1992

[Not value to the systematic study of different tumor markers for disclosing bone metastasis]

[Perception of cancer by general practitioners. Development over 15 years]

scientific article published on 01 May 1993

[Prostate carcinoma in the elderly]

scientific article published on 01 May 2008

[Radiofrequency ablation in the treatment of liver and lung tumors]

scientific article published on 01 November 2009

[Refining the French system of cost assessment for oncology patients following chemotherapy]

scientific article published on 01 November 2003

[Renal cell carcinoma: the end of a tunnel?]

scientific article published on 10 March 2006

[Revision of therapeutic index for targeted treatment in kidney cancer: What if toxicity could predict efficacy?]

scientific article published on 01 June 2014

[Strategy in advanced castration-resistant prostate cancer]

scientific article published on 01 July 2012

[Study of bioavailability parameters of propranolol in cirrhotic patients after oral administration of the delayed-action form]

scientific article published on 01 March 1987

[Symptomatic treatment of pain in cervico-facial cancers]

scientific article published on 01 January 1992

[Systemic chemotherapy in metastatic colorectal adenocarcinomas]

scientific article published on 01 January 1992

[The mechanism of tumor angiogenesis]

scientific article published on 01 February 2007

[Treatment of cancer of the kidney with interleukin 2 in adults, the Lyon experience]

scientific article published on 01 June 1992

[Update on renal cell carcinoma]

scientific article published on 01 January 2002

m-TOR inhibitor as potential radiosensitizer for head and neck squamous cell carcinoma: A case report of an organ transplant patient and review of the literature

scientific article published on 30 August 2016

mTOR inhibitors: temsirolimus and everolimus in the treatment of renal cell carcinoma

scientific article published in January 2010

Paulina is supported by:

About Paulina

Help